22 Oct 2026, 09:17 IST
Nucelion Therapeutics
Tata Asset Management Pvt. Ltd. (Tata Mutual Fund)
The report states Nucelion Therapeutics partnered with VeGen Bio to manufacture a cancer treatment, entering the cell and gene therapy segment.
From TATA MF Daily Market Monitor, written by Tata Asset Management Pvt. Ltd. (Tata Mutual Fund) and hosted by Tata Mutual Fund. Orivam summarised it; the view is Tata Asset Management Pvt. Ltd. (Tata Mutual Fund)'s, not Orivam's.
Open the original PDF on Tata Mutual Fund →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.